Laser and optical imaging developer Advanced Research Technologies (ART) of Montreal and GE Medical Systems of Waukesha, WI, have closed the sale of ART’s small animal molecular imager (SAMI) product to Basel, Switzerland-based Novartis Pharma. SAMI is an optical fluorescence molecular imaging device developed to help pharmaceutical companies and research laboratories better understand disease and reduce the development cycle for new drugs, ART said.
By AuntMinnie.com staff writersOctober 21, 2003
Related Reading
GE, ART alliance notch first sale, September 23, 2003
ART starts clinical trials, September 19, 2003
GE expands ART relationship, August 14, 2003
FDA clears mobile version of GE’s Discovery ST PET/CT, March 31, 2003
GE inks deal with optical imaging firm, October 25, 2002
Copyright © 2003 AuntMinnie.com
